Development of breast cancer in women is dependent on diverse factors,
including genetic predisposition, exposure to both exogenous and endo
genous chemicals, which can modulate initiation, promotion and progres
sion of this disease, and the timing of exposure to these agents. Seve
ral compounds-including 16 alpha-hydroxyestrone (16 alpha-OHE1), catec
holestrogens, and aromatic amines-have been proposed as initiators of
mammary carcinogenesis in humans; however, their role as genotoxins is
unconfirmed. Lifetime exposure to estrogens has been established as a
n important risk factor for breast cancer, and it has been suggested t
hat xenoestrogens may directly add to the hormonal risk or indirectly
increase risk by decreasing 2-hydroxyestrone (2-OHE1)/16 alpha-OHE1 me
tabolite ratios. Results of recent studies suggest that chemical-induc
ed modulation of 2-OHE1/16 alpha-OHE1 metabolite ratios is not predict
ive of xenoestrogens or mammary carcinogens. Moreover, based on curren
t known dietary intakes of natural and xenoestrogenic/antiestrogenic c
hemicals, it is unlikely that xenoestrogens contribute significantly t
o a woman's overall lifetime exposure to estrogens. More information i
s required on the identities and serum levels of both natural and xeno
endocrine active compounds, their concentrations in serum, and the mam
mary gland and levels of these compounds at critical periods of exposu
re.